Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Short intervention program for individuals who attempted suicide in Sweden

Official title: A Randomized Clinical Study of "Attempted Suicide Short Intervention Program" in Swedish Healthcare - ASSIP

Run by Region Skane · NCT04746261 · Data updated 2026-11-12

This study is testing a new short program for people in Sweden who have recently tried to take their own life to see if it can help prevent future attempts when combined with regular treatment.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment460 (estimated)
SponsorRegion Skane
Academic / other
Locations2 sites (Lund and 1 other locations)
StatusRecruiting
StartedOctober 15, 2020
Main results expectedJune 30, 2026
Study endsSeptember 30, 2026
Registry record updatedAugust 20, 2025
Trial IDNCT04746261 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older who have recently attempted suicide and are receiving psychiatric care.

Probably not a fit

Patients with psychotic illnesses, severe personality disorders, or those unable to provide informed consent may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the Attempted Suicide Short Intervention Program (ASSIP) as a treatment for individuals who have recently attempted suicide. Conducted across six psychiatric clinics in Sweden, the study will recruit 460 patients who will be randomized to receive ASSIP alongside standard treatment or standard treatment alone. The trial aims to assess the effectiveness of ASSIP in preventing future suicide attempts and to identify factors that may influence its success. Additionally, the study will explore the economic benefits of implementing ASSIP in healthcare settings.

Why it matters

Potential benefit: If successful, this intervention could significantly reduce the risk of future suicide attempts among patients.

How similar studies have gone: Previous studies, including a randomized controlled trial in Switzerland, have shown promising results for ASSIP, indicating its potential effectiveness.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥18 years.
* Signed informed consent to participate in the study.
* Contact with psychiatric health care after a suicide attempt within 3 months before the baseline visit
* Booked meeting or visit in psychiatry or primary care after visit 1

Exclusion Criteria:

* Psychotic illness with current delusions, hallucinations or other negative symptoms that may affect the therapy.
* Known emotionally unstable personality disorder (ICD 10) noted in the medical record
* Inability to undergo therapy without an interpreter
* Mental retardation, dementia, or other circumstances that make it difficult to understand the meaning of participating in the study and giving informed consent.

Where it's running

  • Region Skåne, psykiatri & habilitering, psykiatriforskning skane, Vuxenpsykiatri Lud
    Lund, Sweden
    Recruiting
  • Region Skåne, psykiatri & habilitering, psykiatriforskning skane,Vuxenpsykiatri Malmoe
    Malmö, Sweden
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.